2018
Primary hepatic neuroendocrine carcinoma: report of two cases and literature review
Zhao ZM, Wang J, Ugwuowo UC, Wang L, Townsend JP. Primary hepatic neuroendocrine carcinoma: report of two cases and literature review. BMC Clinical Pathology 2018, 18: 3. PMID: 29507528, PMCID: PMC5831736, DOI: 10.1186/s12907-018-0070-7.Peer-Reviewed Case Reports and Technical NotesTranscatheter arterial chemoembolizationTreatment optionsLiver biopsyNeuroendocrine carcinomaSomatostatin analoguesLiver protectionLiver lobeNon-hepatic originHepatic hilar lymph nodesSmall cell neuroendocrine carcinomaHepatic neuroendocrine carcinomaIneffective treatment optionsSymptoms of jaundiceInitial hospital admissionHilar lymph nodesSurvival of patientsLimited treatment optionsRight liver lobeUnique clinical featuresAvailable treatment optionsHepatic portal veinAbdominal painLiver transplantSurgical resectionArterial chemoembolization
2015
The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States
Durham DP, Skrip LA, Bruce RD, Vilarinho S, Elbasha EH, Galvani AP, Townsend JP. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States. Clinical Infectious Diseases 2015, 62: 298-304. PMID: 26628566, PMCID: PMC4706637, DOI: 10.1093/cid/civ894.Peer-Reviewed Original ResearchConceptsHepatitis C virusInterferon-free DAAsHCV incidenceTreatment ratesChronic hepatitis C virusCases of cirrhosisInjection drug useImpact of administrationAnnual treatment ratesEnhanced screeningHCV prevalenceHCV screeningDecompensated cirrhosisHCV infectionHCV transmissionHepatitis CLiver transplantActing antiviralsLevels of screeningPatients 4C virusHepatocellular carcinomaEpidemiological dataUniversal screeningDrug use